Long-term Kidney Transplant Survival Across the Globe

Author:

Hariharan Sundaram1,Rogers Natasha2,Naesens Maarten3,Pestana J. Medina4,Ferreira Gustavo F.4,Requião-Moura Lucio R.4,Foresto Renato D.4,Kim S. Joseph5,Sullivan Katrina6,Helanterä Ilkka7,Goutaudier Valentin8,Loupy Alexandre9,Kute Vivek B.10,Cardillo Massimo11,Tanabe Kazunari12,Åsberg Anders13,Jensen Trond14,Mahillo Beatriz15,Jeong Jong Cheol16,Anantharaman Vathsala17,Callaghan Chris18,Ravanan Rommel19,Manas Derek20,Israni Ajay K.21,Mehta Rajil B.1

Affiliation:

1. Department of Medicine and Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

2. Division of Nephrology and Transplantation, Department of Nephrology and Transplantation Medicine, Westmead Institute for Medical Research, Westmead, NSW, Australia.

3. Department of Medicine and Nephrology, University of KU Leuven, Leuven, Belgium.

4. Hospital do Rim, Fundação Oswaldo Ramos and Disciplina de Nefrologia, Universidade Federal de São Paulo, São Paulo, Brazil.

5. Department of Medicine (Nephrology), University of Toronto, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

6. Canadian Institute for Health Information, Toronto, ON, Canada.

7. Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

8. Université Paris Cité, Paris Institute for Transplantation and Organ Regeneration, Paris, France.

9. Department of Nephrology and Transplantation, Université Paris Cité, Paris Institute for Transplantation and Organ Regeneration, Paris, France.

10. Department of Nephology, Institute of Kidney Diseases and Research Centre, Ahmedabad, Gujarat, India.

11. Centro Nazionale per i Trapianti, Istituto Superiore di Sanità, Roma, Italy.

12. Kidney Transplant/Robotic Surgery Center, Shonan Kamakura General Hospital, Kamakura, Japan.

13. Section of Pharmacology and Pharmaceutical Bioscience, University of Oslo, Oslo, Norway.

14. Department of Nephrology, University of Oslo, Oslo, Norway.

15. Organización Nacional de Trasplantes, Madrid, Spain.

16. Department of Medicine and Nephrology, Seoul National University Bundang Hospital, Seoul, South Korea.

17. National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

18. Department of Nephrology and Transplantation, Guy’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom.

19. NHS Blood and Transplant, Bristol, United Kingdom.

20. Newcastle Hospitals NHS Trust and Newcastle University, New Castle, United Kingdom.

21. Department of Medicine, Adjunct Faculty School of Public Health, University of Minnesota, Minneapolis, MN.

Abstract

Background. The outcomes after kidney transplantation (KT), including access, wait time, and other issues around the globe, have been studied. However, issues do vary from one country to another. Methods. We obtained data from several countries from North America, South America, Europe, Asia, and Australia, including the number of patients awaiting KT from 2015, transplant rate per million population (pmp), proportion of living donor and deceased donor (LD/DD) KT, and posttransplant survival. We also sought opinions on key difficulties faced by each of these countries with respect to KT and long-term survival. Results. Variation in access to KT across the globe was noted. Countries with the highest rates of KT pmp included the United States (79%) and Spain (71%). A higher proportion of LD transplants was noted in Japan (93%), India (85%), Singapore (63%), and South Korea (63%). A higher proportion of DD KTs was noted in Spain (90%), Brazil (90%), France (85%), Italy (85%), Finland (85%), Australia–New Zealand (80%), and the United States (77%). The 5-y graft survival for LD was highest in South Korea (95%), Singapore (94%), Italy (93%), Finland (93%), and Japan (93%), whereas for DD, it was South Korea (93%), Italy (88%), Japan (86%), and Singapore (86%). The common issues surrounding KTs are access and a limited number of LDs and DDs. Key issues identified for long-term survival were increasing age of donors and recipients, higher recipient comorbidity, and posttransplant events, such as alloimmune injury to the kidney, infection, cancer, and suboptimal adherence to therapy. Conclusions. A unified approach is necessary to improve issues surrounding KT as the demand continues to increase.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3